Gene: CLDND1
Official Full Name: claudin domain containing 1provided by HGNC
Gene Summary: Located in cell surface. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18672 | CLDND1 Knockout cell line (HeLa) | Human | CLDND1 | 1:3~1:6 | Negative | Online Inquiry |
KO18673 | CLDND1 Knockout cell line (HCT 116) | Human | CLDND1 | 1:2~1:4 | Negative | Online Inquiry |
KO18674 | CLDND1 Knockout cell line (HEK293) | Human | CLDND1 | 1:3~1:6 | Negative | Online Inquiry |
KO18675 | CLDND1 Knockout cell line (A549) | Human | CLDND1 | 1:3~1:4 | Negative | Online Inquiry |
CLDND1 Gene Knockout Cell Lines represent a cutting-edge tool in molecular biology designed to facilitate the study of genetic function and cellular processes related to the CLDND1 gene. These cell lines are engineered using CRISPR-Cas9 technology to create specific gene knockouts, inhibiting the expression of the CLDND1 protein. This enables researchers to investigate the role of CLDND1 in a variety of biological contexts, including cell signaling, membrane dynamics, and metabolic pathways.
The fundamental mechanism of these knockout cell lines relies on the precise alteration of the host genome, effectively removing the gene of interest. This approach allows for the observation of phenotypic changes and the exploration of compensatory mechanisms, providing insights into the biological pathways influenced by CLDND1. The ability to manipulate gene expression with high specificity and efficiency represents a significant advancement in functional genomics and cellular biology research.
From a scientific perspective, the applications of CLDND1 Gene Knockout Cell Lines are vast, encompassing drug discovery, disease modeling, and understanding pathophysiological mechanisms. They provide valuable platforms for screening potential therapeutics and for elucidating the gene's involvement in diseases such as cancer or neurodegenerative disorders.
One key advantage of CLDND1 Gene Knockout Cell Lines is their production through a standardized and reproducible method, which ensures a high efficacy of gene disruption and consistency across experiments. In comparison to traditional gene silencing methods such as siRNA, these knockout lines provide a permanent and stable solution for functional studies, making them more suited for long-term research projects.
For researchers and clinicians focused on genetic investigations and therapeutic development, the use of CLDND1 Gene Knockout Cell Lines offers unparalleled value. By accurately modeling the absence of specific genes, these products empower users to foster breakthroughs in their understanding of gene function and its implications in various biological processes.
Our company specializes in innovative biological solutions that support advanced research and clinical applications. With a commitment to quality and scientific integrity, we provide products that empower researchers to drive discoveries at the forefront of life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.